First line support for your high risk patients
Learn more about the comprehensive range of solutions from respiratory support, IABP therapy and Extracorporeal Life Support (ECLS) including advanced monitoring devices that can help to solve therapeutic conflicts.
The why, when and who of mechanical circulatory support
The intra-aortic balloon pump (IABP) has long been the first-line choice for mechanical circulatory support due to its clinical efficacy, safety profile across a broad range of patient care scenarios, and low cost.
Recent debate regarding the IABP has centered on the discrepant results obtained from randomized, controlled trials (RCTs), versus the benefits observed by clinicians in decades of clinical practice.
This series of educational programs reviews the physiological principles behind current circulatory support therapies.
Hemodynamic effects of standard vs. larger-capacity intra-aortic balloon counterpulsation pumps
The first reported patient comparison on 40cc vs. 50cc supports our bench test results - 50cc IABP may yield better clinical outcomes than standard 40cc IABP. The 50cc IABP provides:
- Greater diastolic augmentation and provides greater systolic unloading
- Significant decrease in cardiac filling pressures and increase of cardiac output
Device Options in the Cath Lab - Practical Patient Support
Joseph L. Thomas, MD, FSCAI
Assistant Health Science Clinical Professor David Geffen School of Medicine
Director, Interventional Cardiology Harbor-UCLA Medical Center
The use of percutaneous mechanical circulatory support (MCS) has been rapidly evolving as devices become smaller, more efficient, easier to deploy, and less invasive. The purpose of this session is to share an expert's experience on the use of counterpulsation therapy in the treatment of patients at high risk for cardiovascular compromise during percutaneous coronary intervention considering current evidence, risk of complication, and cost.
IABP Therapy Theory Program
This interactive program is designed for health care professionals with experience in critical care and hemodynamic monitoring, who treat patients requiring Intra-aortic Balloon Pump counterpulsation.
The program covers the historical, theoretical, and clinical considerations for patients receiving counterpulsation therapy.
This program has been approved by the American Association of Critical-Care Nurses (AACN) for 1.5 CERP, Synergy CERP Category A. This program has been approved for a maximum of 1.5 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care.
Get your free copy of a special Cardiology Today's Intervention supplement!
Treatments, timing and a tomorrow for patients in cardiogenic shock
In this sixteen page Cardiology Today’s Intervention spotlight supplement, leading interventional cardiologists examine the definition, etiology and diagnosis of cardiogenic shock. Current treatment options, such as IABPs and other mechanical circulatory support devices, are explored, and a review of the research pertaining to these devices is discussed. Finally, the cost effectiveness of these treatment options is considered.
Produced by SLACK, and sponsored by Getinge.
PiCCO-Technology is the easy, less invasive and cost-efficient tool for determining the main hemodynamic parameters of critically ill patients.
The CARDIOHELP System is the world’s smallest, portable heart-lung support system making it ideal for transporting patients within and outside the hospital while on circulatory and / or pulmonary support, up to 6 hours.
SERVO is the leading ventilation brand with unmatched flexibility for patients of all sizes. Personalized ventilation provides unique patient insight and ventilation capabilities.
Intra-Aortic Balloon Pump (IABP) therapy helps the heart by increasing oxygen to the heart while decreasing its workload. Getinge offers innovative pumps and balloons designed for this therapy as well as portable options for patient transport.